HERON THERAPEUTICS, INC. /DE/ - HRTX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Clearline Capital LP | 6.7% | 12,235,239 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Clearline Capital LLC | 6.7% | 12,235,239 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Marc Majzner | 6.7% | 12,235,239 | View |
| Jan 30, 2026 | SCHEDULE 13G | The Vanguard Group | 5.35% | 9,820,384 | View |
| Nov 26, 2025 | SCHEDULE 13G | Clearline Capital LP | 5.3% | 9,712,527 | View |
| Nov 26, 2025 | SCHEDULE 13G | Clearline Capital LLC | 5.3% | 9,712,527 | View |
| Nov 26, 2025 | SCHEDULE 13G | Marc Majzner | 5.3% | 9,712,527 | View |
| Oct 30, 2025 | SCHEDULE 13G/A | The Vanguard Group | 4.61% | 8,459,784 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.